Barr's Seasonique Is "Approvable" Pending Data On The Contraceptive's Regimen
This article was originally published in The Pink Sheet Daily
Executive Summary
The firm is seeking a meeting with FDA to discuss use of results from ongoing studies of the extended-regimen oral contraceptive.
You may also be interested in...
Role Reversal: Barr May Seek A Settlement To Thwart Generic Seasonale
Barr's request for patent re-issue was rejected by PTO, opening the door for Watson to launch generic Seasonale in September.
Role Reversal: Barr May Seek A Settlement To Thwart Generic Seasonale
Barr's request for patent re-issue was rejected by PTO, opening the door for Watson to launch generic Seasonale in September.
Additional Seasonique Data Not Required To Support Extended-Cycle Approval, Barr Says
The firm anticipates approval of the 91-day cycle contraceptive in "a couple months."